A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms

CompletedOBSERVATIONAL
Enrollment

117

Participants

Timeline

Start Date

July 20, 2016

Primary Completion Date

February 2, 2017

Study Completion Date

February 2, 2017

Conditions
Myelodysplastic SyndromesLeukemia Myeloid AcuteMultiple MyelomaLeukemia, Lymphocytic, Chronic, B-Cell
Trial Locations (15)

15006

C.H. Universitario A Coruña, A Coruña

28007

Hospital U. Gregorio Marañón, Madrid

28031

Hospital Infanta Leonor, Madrid

31008

C. H. Navarra, Pamplona

33006

Hospital Universitario Central de Asturias, Oviedo

38010

Hospital Ntra. Sra. La Candelaria, Santa Cruz de Tenerife

38320

Hospital Universitario de Canarias, San Cristóbal de La Laguna

40002

Hospital de Segovia, Segovia

46026

Hospital La Fe, Valencia

46600

Hospital La Ribera, Alzira

08916

Hospital Germans Trias i Pujol, Badalona

08908

Hospital Durán I Reynals, L'Hospitalet de Llobregat

08208

Hospital Parc Taulí, Sabadell

08035

Hospital Vall d' Hebrón, Barcelona

01009

Hospital Txagorritxu, Vitoria-Gasteiz

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY